Difficulty: Medium
Average Score: 65%
Practice
In the context of neonatal respiratory distress syndrome (RDS), which of the following is typically administered?
Correct answer
B
Rationale
In the context of neonatal respiratory distress syndrome (RDS), the correct answer is B) corticosteroids.
Rationale:
Corticosteroids are typically administered in neonates with RDS to help reduce inflammation in the lungs, improve lung function, and enhance the production of surfactant which aids in breathing. Surfactant deficiency is a key factor in the development of RDS in premature infants, and corticosteroids can help stimulate surfactant production, thereby improving respiratory function.
Why the other options are wrong:
A) Antibiotics are not typically administered for RDS as it is a condition primarily related to lung immaturity and surfactant deficiency, not an infection.
C) Bronchodilators are not indicated for RDS as the primary issue is not bronchoconstriction but rather surfactant deficiency and lung immaturity.
D) Oxygen therapy is a supportive measure in RDS to maintain adequate oxygen levels, but corticosteroids address the underlying inflammatory process and surfactant deficiency more directly.
Educational context:
Understanding the appropriate pharmacological interventions for neonatal RDS is crucial for nurses and healthcare providers working in neonatal care settings. Corticosteroids play a vital role in managing RDS by addressing the underlying pathophysiology of the condition. This knowledge is essential for providing safe and effective care to neonates with respiratory distress syndrome.
Rationale:
Corticosteroids are typically administered in neonates with RDS to help reduce inflammation in the lungs, improve lung function, and enhance the production of surfactant which aids in breathing. Surfactant deficiency is a key factor in the development of RDS in premature infants, and corticosteroids can help stimulate surfactant production, thereby improving respiratory function.
Why the other options are wrong:
A) Antibiotics are not typically administered for RDS as it is a condition primarily related to lung immaturity and surfactant deficiency, not an infection.
C) Bronchodilators are not indicated for RDS as the primary issue is not bronchoconstriction but rather surfactant deficiency and lung immaturity.
D) Oxygen therapy is a supportive measure in RDS to maintain adequate oxygen levels, but corticosteroids address the underlying inflammatory process and surfactant deficiency more directly.
Educational context:
Understanding the appropriate pharmacological interventions for neonatal RDS is crucial for nurses and healthcare providers working in neonatal care settings. Corticosteroids play a vital role in managing RDS by addressing the underlying pathophysiology of the condition. This knowledge is essential for providing safe and effective care to neonates with respiratory distress syndrome.